B4 Hand Sanitizer

B4 Hand Sanitizer Manufacturers

• Midway Advanced Products, Llc
  

  ×

  B4 Hand Sanitizer | Apotex Corp.

  

  ---

  2.1 General Considerations

  The usual starting dose is valsartan and hydrochlorothiazide tablets 160/12.5 mg once daily. The dosage can be increased after 1 to 2 weeks of therapy to a maximum of one 320/25 tablet once daily as needed to control blood pressure [see Clinical Studies (14.2)]. Maximum antihypertensive effects are attained within 2 to 4 weeks after a change in dose.

  2.2 Add-On Therapy

  A patient whose blood pressure is not adequately controlled with valsartan (or another ARB) alone or hydrochlorothiazide alone may be switched to combination therapy with valsartan and hydrochlorothiazide tablets.

  A patient who experiences dose-limiting adverse reactions on either component alone may be switched to valsartan and hydrochlorothiazide tablets containing a lower dose of that component in combination with the other to achieve similar blood pressure reductions. The clinical response to valsartan and hydrochlorothiazide tablets should be subsequently evaluated and if blood pressure remains uncontrolled after 3 to 4 weeks of therapy, the dose may be titrated up to a maximum of 320/25 mg.

  2.3 Replacement Therapy

  Valsartan and hydrochlorothiazide tablets may be substituted for the titrated components.

  2.4 Initial Therapy

  Valsartan and hydrochlorothiazide tablets are not recommended as initial therapy in patients with intravascular volume depletion [see Warnings and Precautions (5.2)].

  2.5 Use with Other Antihypertensive Drugs

  Valsartan and hydrochlorothiazide tablets may be administered with other antihypertensive agents.

  Close
  No Recall

  More Info